基本數據
| CIK | 889232 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Investor AB (publ)
SEC Filings (Chronological Order)
本頁面提供了一個完整的、按時間順序排列的美國證券交易委員會（SEC）申報文件列表，不包括我們在其他地方提供的所有權申報。
| May 21, 2024 |
SC 13D 1 ef20029485sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* LM ERICSSON TELEPHONE COMPANY (Translation of registrant’s name into English) (Name of Issuer) Class B Shares (SEK 5.00 nominal value) (Title of Class of Securities) 294821608** (CUSIP Number) Petra Hedengran Managing Di |
|
| November 6, 2023 |
NDAQ / Nasdaq Inc - 144A / INVESTOR AB - SC 13D/A Activist Investment SC 13D/A 1 ef20014111sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE- |
|
| December 16, 2022 |
NDAQ / Nasdaq Inc / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00 |
|
| August 26, 2022 |
NDAQ / Nasdaq Inc / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00 |
|
| June 27, 2022 |
ABB / ABB Ltd. / INVESTOR AB Activist Investment SC 13D/A 1 formsc13da.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New |
|
| June 22, 2021 |
ABB / ABB Ltd. / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| April 24, 2020 |
EX-99.6 2 ex996.htm EXHIBIT 99.6 EXHIBIT 6 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Shares of Nasdaq, Inc. and further agree that this Joint Filing Agreement shall |
|
| April 24, 2020 |
NDAQ / Nasdaq, Inc. / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00 |
|
| March 6, 2020 |
ABB / ABB Ltd. / INVESTOR AB Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| May 22, 2019 |
ABB / ABB Ltd. / INVESTOR AB - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| February 14, 2019 |
CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 14, 2018 |
SC 13G/A 1 chinacac13gam5dec2017.htm CHINACACHE INTERNATIONAL 13G AMENDMENT NO. 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 31, 20 |
|
| February 14, 2017 |
SC 13G/A 1 chinacac13gam4dec2016.htm CHINACACHE INTERNATIONAL HOLDINGS LTD. SC 13G/AM4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 3 |
|
| May 29, 2015 |
ABB / ABB Ltd. / INVESTOR AB - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 1.03 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| February 17, 2015 |
AGRX / Agile Therapeutics, Inc. / INVESTOR AB - AGILE THERAPEUTICS SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Agile Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00847L100 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 17, 2015 |
CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - AMENDMENT NO. 3 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| May 12, 2014 |
ABB / ABB Ltd. / INVESTOR AB - ABB LTD Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 1.03 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842 |
|
| February 14, 2014 |
TNGO / Tangoe, Inc. / INVESTOR AB - AMENDMENT NO. 2 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* TANGOE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 87582Y108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| May 15, 2013 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2013 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| February 14, 2013 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2012 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| February 13, 2013 |
GWAY / Greenway Medical Technologies Inc / INVESTOR AB - GREENWAY SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 13, 2013 |
TNGO / Tangoe, Inc. / INVESTOR AB - CHINA13GAM2DEC12 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 13, 2013 |
TNGO / Tangoe, Inc. / INVESTOR AB - TANGOE13GAM1FEB13 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 14, 2012 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2012 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| August 14, 2012 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2012 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| May 15, 2012 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2012 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| May 10, 2012 |
MATR / Mattersight Corp. / INVESTOR AB - SC 13D AMENDMENT 1 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mattersight Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 577097108 (CUSIP Number) Anthony O. Pergola, Esq. Richard Bernstein, Esq. Lowenstein Sandler PC 1251 Avenue of the Americas, 17th Floor New Yo |
|
| February 14, 2012 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2011 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| February 13, 2012 |
CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - AMENDMENT NO. 1 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| January 18, 2012 |
TNGO / Tangoe, Inc. / INVESTOR AB - TANGOE13GDEC11 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* TANGOE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 87582Y108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| December 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MATTERSIGHT CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 577097108 (CUSIP Number) Anthony O. Pergola, Esq. Richard Bernstein, Esq. Lowenstein Sandler PC 1251 Avenue of the Americas, 18th Floor New Yor |
|
| November 14, 2011 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2011 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| August 15, 2011 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2011 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| May 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: 3/31/2011 Check here if Amendment []; Amendment Number: - This Amendment (Check only one.): [] is a restatement. [] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S-103, 23 S |
|
| March 10, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* THE NASDAQ OMX GROUP, inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, A |
|
| February 14, 2011 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2010 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| February 14, 2011 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. |
|
| February 11, 2011 |
Schedule 13G (Amendment No. 3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) C |
|
| February 11, 2011 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary s |
|
| February 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary shares of par value of $0.0001 per share (Title of Class of Securities) G21191 104 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropri |
|
| February 9, 2011 |
EXHIBIT 4 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of February 7, 2011 by and between each of the sellers named in Schedule I hereto (each, a “Seller,” and, collectively, the “Sellers”), on the one hand, and Investor Trading AB (the “Purchaser”), on the other hand. |
|
| February 9, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* THE NASDAQ OMX GROUP, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, A |
|
| January 24, 2011 |
NASDAQ STOCKHOLDERS’ AGREEMENT dated as of December 16, 2010 THE NASDAQ OMX GROUP, INC. INVESTOR AB EXHIBIT 2 EXECUTION VERSION NASDAQ STOCKHOLDERS’ AGREEMENT dated as of December 16, 2010 between THE NASDAQ OMX GROUP, INC. |
|
| January 24, 2011 |
EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Shares of The NASDAQ OMX Group, Inc. |
|
| January 24, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* THE NASDAQ OMX GROUP, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, Ad |
|
| November 12, 2010 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2010 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| August 27, 2010 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2010 Check here if Amendment [X]: This Amendment (Check only one. |
|
| August 27, 2010 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2010 Check here if Amendment [X]: This Amendment (Check only one. |
|
| August 16, 2010 |
FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2010 Check here if Amendment [ ]: This Amendment (Check only one. |
|
| May 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: 3/31/2010 Check here if Amendment []; Amendment Number: - This Amendment (Check only one.): [] is a restatement. [] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S-103, 23 S |
|
| February 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2009 Check here if Amendment [ ]; Amendment Number: [ ] This Amendment (Check only one. |
|
| January 22, 2010 |
Schedule 13G Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Ch |
|
| December 29, 2008 |
Schedule 13G Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 18, 2008 (Date of Event Which Requires Filing of this Statement) Ch |
|
| October 20, 2008 |
As filed with the Securities and Exchange Commission on October 20, 2008 Registration No. |
|
| October 20, 2008 |
AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents One-Half of One (1/2) Share) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR COMMON STOCK, NO PAR VALUE, OF INVESTOR AB (INCORPORATED UNDER THE LAWS OF SWEDEN) The Bank of New York Mellon, as depositary (hereinafter called the “Depositary”), hereby certifies (i) that there have been deposited with the Depositary o |
|
| October 20, 2008 |
EXHIBIT 4 Writer’s Direct Dial EMMET, MARVIN & MARTIN, LLP COUNSELLORS AT LAW 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www. |
|
| September 4, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title or Class of Securities) 00448Q201 (CUSIP Number) August 12, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 9, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2006 Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, |
|
| November 13, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2006 Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, |
|
| August 10, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2006 Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S-10 |
|
| May 15, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2006 Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S-1 |
|
| February 21, 2006 |
AMENDMENT 2; DECEMBER 31, 2005 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* ABB LTD. - (Name of Issuer) Registered Shares, CHF 2.50 nominal value - (Title of Class of Securities) CH0012221716 - (CUSIP Number) James E. Kaye, Esq. Akin Gump Strauss Hauer & Feld LLP 590 Madison Avenue New York, New York 10022 (212) 872-1000 - (Name |
|
| February 14, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2005 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S- |
|
| November 14, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2005 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report:; Name: Investor AB Address: Arsenalsgatan 8C, |
|
| July 27, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2005 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S-103, |
|
| May 13, 2005 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: December 31, 2006 Estimated average burden hours per response: . |
|
| April 8, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* ISTA PHARMACEUTICALS, INC. - (Name of Issuer) Common Stock, Par Value $.001 Per Share - (Title of Class of Securities) 45031X105 - (CUSIP Number) James E. Kaye, Esq. Akin Gump Strauss Hauer & Feld LLP 590 Madison Avenue New York, New York 10022 (212) 872 |
|
| April 7, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* TESSERA TECHNOLOGIES, INC. - (Name of Issuer) Common Stock, Par Value $.001 Per Share - (Title of Class of Securities) 88164L100 - (CUSIP Number) James E. Kaye, Esq. Akin Gump Strauss Hauer & Feld LLP 590 Madison Avenue New York, New York 10022 (212) 872 |
|
| March 8, 2005 |
SC 13D/A 1 abbltd13da1-030405.txt AMENDMENT 1; 030405 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* ABB LTD. - (Name of Issuer) Registered Shares, CHF 2.50 nominal value - (Title of Class of Securities) CH0012221716 - (CUSIP Number) James E. Kaye, Esq. Akin Gump Strauss Hauer & Feld LLP 590 Madison |
|
| February 15, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* KYPHON INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 501577100 (CUSIP Number) December 31, 2004 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| February 14, 2005 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: December 31, 2006 Estimated average burden hours per response: . |
|
| February 7, 2005 |
WARRANT TO PURCHASE COMMON STOCK OF INNOVATIVE MICRO TECHNOLOGY, INC. EX-99.B 3 dex99b.htm WARRANT TO PURCHASE TO COMMON STOCK Exhibit B THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS (i) A REGISTRATION STATEMENT UNDER THE ACT, |
|
| February 7, 2005 |
Innovative Micro Technology, Inc. Voting Agreement EX-99.D 5 dex99d.htm VOTING AGREEMENT Exhibit D Execution Copy Innovative Micro Technology, Inc. Voting Agreement This Voting Agreement (this “Agreement”) is made as of January 25, 2005 by and among Innovative Micro Technology, Inc., a Delaware corporation (the “Company”), the stockholders listed on the signature pages hereto (the “Current Stockholders”) and the investors listed on Schedule I here |
|
| February 7, 2005 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovative Micro Technology, Inc. (Name of Issuer) Common Stock, par value $.0001 (Title of Class of Securities) 038-213-104 (CUSIP Number) Investor AB Arsenalsgatatan 8C S-103-32 Stockholm Sweden V7 Tel: 46 8 614 21 50 (Name, Address and Telephone Number of Person Aut |
|
| February 7, 2005 |
Innovative Micro Technology, Inc. Right of First Refusal and Co-Sale Agreement EX-99.E 6 dex99e.htm CO-SALE AGREEMENT Exhibit E Execution Copy Innovative Micro Technology, Inc. Right of First Refusal and Co-Sale Agreement This Right of First Refusal and Co-Sale Agreement (this “Agreement”) is made as of January 25, 2005 by and among Innovative Micro Technology, Inc., a Delaware corporation (the “Company”), the stockholders listed on the signature pages hereto (the “Current S |
|
| February 7, 2005 |
EX-99.C 4 dex99c.htm INVESTOR'S RIGHTS AGREEMENT Exhibit C Execution Copy Innovative Micro Technology, Inc. INVESTORS’ RIGHTS AGREEMENT Dated as of January 25, 2005 TABLE OF CONTENTS Page ARTICLE I Definitions 1 1.1 Definition of Terms 1 1.2 Construction 4 ARTICLE II Registration Rights 5 2.1 Request for Registration 5 2.2 Registration Incidental to Company Registration 6 2.3 S-3 Registration 6 2. |
|
| February 7, 2005 |
WARRANT TO PURCHASE COMMON STOCK OF INNOVATIVE MICRO TECHNOLOGY, INC. EX-99.A 2 dex99a.htm WARRANT TO PURCHASE TO COMMON STOCK Exhibit A THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS (i) A REGISTRATION STATEMENT UNDER THE ACT, |
|
| November 12, 2004 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: December 31, 2006 Estimated average burden hours per response: . |
|
| November 3, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* TESSERA TECHNOLOGIES, INC. (Name of Issuer) Common Stock, Par Value $.001 Per Share (Title of Class of Securities) 88164L100 (CUSIP Number) James E. Kaye, Esq. Akin Gump Strauss Hauer & Feld LLP 590 Madison Avenue New York, New York 10022 (212) 872-1000 |
|
| August 4, 2004 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: December 31, 2006 Estimated average burden hours per response: . |
|
| May 14, 2004 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: December 31, 2006 Estimated average burden hours per response: . |
|
| April 1, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* TESSERA TECHNOLOGIES, INC. - (Name of Issuer) Common Stock, Par Value $0.001 Per Share - (Title of Class of Securities) 88164L100 - (CUSIP Number) James E. Kaye, Esq. Akin, Gump, Strauss, Hauer & Feld, L.L.P. 590 Madison Avenue New York, New York 10022 ( |
|
| February 17, 2004 |
SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1 to SCHEDULE 13D Under the Securities Exchange Act of 1934 AstraZeneca PLC (Name of Issuer) CLASS A SHARES (Title of Class of Securities) G9885J102 (CUSIP Number) Fredrik Lindgren Investor AB Arsenalsgatan 8 c S-103 32 Stockholm Sweden 011-46-8-614-2031 (Name, Address and Telephone Number of Person Auth |
|
| February 13, 2004 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: October 31, 2003 Estimated average burden hours per response: . |
|
| February 4, 2004 |
SC 13G/A 1 kyphon13g-a1123103.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* KYPHON INC. - (Name of Issuer) Common Stock, $0.001 par value per share - (Title of Class of Securities) 501577100 - (CUSIP Number) December 31, 2003 - (Date of Event which Requires Filing of this Statement) Check the ap |
|
| February 3, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* AXCAN PHARMA INC. - (Name of Issuer) Common Stock, No Par Value - (Title of Class of Securities) 054923107 - (CUSIP Number) December 31, 2003 - (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| November 26, 2003 |
SC 13D 1 tessera13d111803.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* TESSERA TECHNOLOGIES, INC. - (Name of Issuer) Common Stock, Par Value $.001 Per Share - (Title of Class of Securities) 88164L100 - (CUSIP Number) James E. Kaye, Esq. Akin, Gump, Strauss, Hauer & Feld, L.L.P. 590 Madison Avenu |
|
| November 12, 2003 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: October 31, 2003 Estimated average burden hours per response: . |
|
| August 13, 2003 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: October 31, 2003 Estimated average burden hours per response: . |
|
| May 13, 2003 |
13F-HR 1 investorab13f-033103.txt FORM 13F MARCH 31, 2003 ................................ . OMB APPROVAL . ................................ .OMB Number: 3235-0006. .Expires: October 31, 2003. .Estimated average . . burden hours per . . response:..............23.5. ................................ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE |
|
| February 14, 2003 |
13F-HR 1 investorab13f-123102.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2002 - Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Inv |
|
| February 14, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Axcan Pharma Inc. - (Name of Issuer) Common Stock, No Par Value - (Title of Class of Securities) 054923107 - (CUSIP Number) December 31, 2002 - (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| February 11, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 KYPHON INC. (Name of Issuer) Common Stock (Title of Class of Securities) 501577 10 0 (CUSIP Number) December 31, 2002 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13 |
|
| November 22, 2002 |
SC 13D 1 nov220213d.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ABB Ltd - (Name of Issuer) Registered Shares - (Title of Class of Securities) CH0012221716 - (CUSIP Number) Paul Kumleben, Esq. Davis Polk & Wardwell 99 Gresham Street London EC2V 7NG United Kingdom 011-44-20-7418-1300 - (Name, Address and Telephone |
|
| November 20, 2002 |
QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.(1)(L) ISTA PHARMACEUTICALS, INC. AMENDMENT TO THE ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT THIS AMENDMENT TO THE ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT (the "Amendment") is made as of November 12, 2002, by and among ISTA Pharmaceuticals, Inc., a Delaware corpo |
|
| November 20, 2002 |
EX-99.(1)(M) 5 a2094139zex-991m.htm EXHIBIT 99.(1)(M) EXHIBIT 99.(1)(M) November , 2002 ISTA Pharmaceuticals, Inc. 15279 Alton Parkway, Suite 100 Irvine, CA 92618 Re: ISTA Pharmaceuticals, Inc.—Lockup Agreement Ladies and Gentlemen: The undersigned understands that ISTA Pharmaceuticals, Inc., a Delaware corporation (the "Company"), has entered into the Common Stock and Warrant Purchase Agreement, |
|
| November 20, 2002 |
EX-99.(1)(I) 3 a2094139zex-991i.htm EXHIBIT 99.(1)(I) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.(1)(I) JOINT FILING STATEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13D/A is filed on behalf of each of us. Dated: November 19, 2002 INVESTOR GROWTH CAPITAL LIMITED /s/ MICHAEL OPORTO Michael Oporto Attorney-in-Fact /s/ BORJE EKHO |
|
| November 20, 2002 |
QuickLinks - Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Amendment No. |
|
| November 6, 2002 |
.................................. . OMB Approval . .................................. . OMB Number: 3235-0006. . Expires: October 31, 2003. . Estimated average . . burden hours per . . response:................23.5. . ................................ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: |
|
| October 15, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Axcan Pharma Inc. - (Name of Issuer) Common Stock, No Par Value - (Title of Class of Securities) 054923107 - (CUSIP Number) October 15, 2002 - (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| September 30, 2002 |
EX-99.1(C) 5 a2090302zex-991c.htm EXHIBIT 99.1(C) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(c) EXHIBIT C POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR GROWTH CAPITAL LIMITED, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for t |
|
| September 30, 2002 |
EX-99.1(B) 4 a2090302zex-991b.htm EXHIBIT 99.1(B) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(b) EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR AB, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose o |
|
| September 30, 2002 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (RULE 13d-101) QuickLinks - Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. |
|
| September 30, 2002 |
EXHIBIT A JOINT FILING STATEMENT EX-99.1(A) 3 a2090302zex-991a.htm EXHIBIT 99.1(A) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(a) EXHIBIT A JOINT FILING STATEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13D is filed on behalf of each of us. Dated: September 30, 2002 INVESTOR GROWTH CAPITAL LIMITED /s/ MICHAEL OPORTO Michael Oporto Attorney-in-Fact /s/ BORJE E |
|
| August 8, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2002 - Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S- |
|
| July 8, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) Scania AB - - (Name of Issuer) CLASS A SHARES CLASS B SHARES - - (Title of Class of Securities) CLASS A SHARES - XL 74244 CLASS B SHARES - XL 74245 - - (CUSIP Number) Paul Kumleben, Esq. Davis Polk & Wardwell 99 Gresham Street London EC2V 7NG United Kingd |
|
| July 8, 2002 |
SC 13D 1 jul0802astrazenca13d.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 AstraZeneca PLC - (Name of Issuer) CLASS A SHARES - (Title of Class of Securities) G9885J102 - (CUSIP Number) Paul Kumleben, Esq. Davis Polk & Wardwell 99 Gresham Street London EC2V 7NG United Kingdom 011-44-20-7418-1360 - (Name, Address a |
|
| July 8, 2002 |
EXHIBIT 1 Share sale and purchase agreement between Investor AB and Volkswagen AG Investor AB ("Investor") holds 54,061,380 A-shares and 1,508,693 B-shares in Scania AB (the "Company"), which is equivalent to 27,79% of the capital and 49,28% of the votes in the Company. |
|
| May 15, 2002 |
13F-HR 1 investorab13f33102.txt .................................. . OMB Approval . .................................. . OMB Number: 3235-0006. . Expires: October 31, 2003. . Estimated average . . burden hours per . . response:................23.5. . ................................ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the |
|
| February 12, 2002 |
13F-HR 1 investor13f-123101.txt .................................. . OMB Approval . .................................. . OMB Number: 3235-0006. . Expires: October 31, 2003. . Estimated average . . burden hours per . . response:................23.5. . ................................ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the |
|
| January 30, 2002 |
SC 13G/A 1 edison13ga1-123101.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EDISON SCHOOLS INC. - (Name of Issuer) Class A Common Stock, $.01 Par Value - (Title of Class of Securities) 281033100 - (CUSIP Number) December 31, 2001 - (Date of Event which Requires Filing of this Statement) Check th |
|
| November 14, 2001 |
13F-HR 1 investorab13f93001.txt ................................. . OMB APPROVAL . ................................. .OMB Number: 3235-0006 . .Expires: October 31, 2003 . .Estimated average . . burden hours per . . response:...............23.5 . ................................. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F COVER PAGE Report for the Cale |
|
| July 31, 2001 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2001 Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): is a restatement. adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8C, S-103, 32 Stockholm, |
|
| June 1, 2001 |
Page 14 of 15 EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR AB, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose outlined below. |
|
| June 1, 2001 |
Page 13 of 15 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13D with respect to the Common Stock of IntraBiotics Pharmaceuticals, Inc. |
|
| June 1, 2001 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AXCAN PHARMA INC. - (Name of Issuer) Common Stock, No Par Value - (Title of Class of Securities) 054923107 - (CUSIP Number) James E. Kaye, Esq. Akin, Gump, Strauss, Hauer & Feld, L.L.P. 590 Madison Avenue New York, New York 10022 (212) 872-1000 - (Name, A |
|
| June 1, 2001 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* INTRABIOTICS PHARMACEUTICALS, INC. - (Name of Issuer) Common Stock, $.001 Par Value - (Title of Class of Securities) 46116T100 - (CUSIP Number) James E. Kaye, Esq. Akin, Gump, Strauss, Hauer & Feld, L.L.P. 590 Madison Avenue New York, New York 10022 (212) |
|
| June 1, 2001 |
15 of 15 Pages EXHIBIT C POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR GROWTH CAPITAL LIMITED, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose outlined below. |
|
| June 1, 2001 |
Page 14 of 15 EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR AB, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose outlined below. |
|
| June 1, 2001 |
Page 15 of 15 EXHIBIT C POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR GROWTH CAPITAL LIMITED, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose outlined below. |
|
| June 1, 2001 |
Page 13 of 15 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13D with respect to the Common Stock of Axcan Pharma Inc. |
|
| May 15, 2001 |
13F-HR 1 investorab13f.txt ............................ OMB APPROVAL ............................ OMB NUMBER: 3235-0006 EXPIRES: OCTOBER 31, 2000 ESTIMATED AVERAGE BURDEN HOURS PER RESPONSE................24.7 ............................ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2001 Check h |
|
| February 14, 2001 |
Page 7 of 7 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR AB, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose outlined below. |
|
| February 14, 2001 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F Cover Page Report for the Calendar Year or Quarter Ended: December 31, 2000 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8c, S- |
|
| February 14, 2001 |
SCH. 13G AMEND #2 RE SYLVAN LEARNING SYSTEMS, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)* SYLVAN LEARNING SYSTEMS, INC. - (Name of Issuer) Common Stock, Par Value $0.01 - (Title of Class of Securities) 871399-10-1 - (CUSIP Number) December 31, |
|
| November 14, 2000 |
- OMB APPROVAL - OMB Number: 3235-0006 Expires: October 31, 2000 Estimated average burden hours per response:. |
|
| October 3, 2000 |
NoSuchKey The specified key does not exist. edgar/data/889232/000092153000000203/0002.txt DEYPM6Q4537CZDS2 N+PPR9+3S1a4K5pUDeKJjvmKhK6ndUEDuh4ZHNY4j/Pe5NjR6yBfSIwH8ZFoAmv/cGR3d3F2R0o= |
|
| October 3, 2000 |
SCHEDULE 13G RE INTUITIVE SURGICAL, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )* INTUITIVE SURGICAL, INC. - (Name of Issuer) Common Stock, Par Value $0.001 - (Title of Class of Securities) 46120E107 - (CUSIP Number) June 13, 2000 - (Da |
|
| September 6, 2000 |
Page 9 of 9 Pages EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Axcan Pharma Inc. |
|
| September 6, 2000 |
Page 9 of 9 Pages EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of IntraBiotics Pharmaceuticals, Inc. |
|
| September 6, 2000 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )* AXCAN PHARMA INC. - (Name of Issuer) Common Stock, No Par Value - (Title of Class of Securities) 054923107 - (CUSIP Number) June 16, 2000 - (Date of Event |
|
| September 6, 2000 |
13G RE INTRABIOTICS PHARMACEUTICALS, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )* INTRABIOTICS PHARAMCEUTICALS, INC. - (Name of Issuer) Common Stock, $.001 Par Value - (Title of Class of Securities) 46116T100 - (CUSIP Number) March 30, |
|
| August 16, 2000 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )* EDISON SCHOOLS INC. (Name of Issuer) Class A Common Stock, $.01 Par Value (Title of Class of Securities) 281033100 (CUSIP Number) December 31, 1999 (Date |
|
| August 14, 2000 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F Form 13F Cover Page Report for the Calendar Year or Quarter Ended: June 30, 2000 Check here if Amendment [ ]; Amendment Number: - This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Investor AB Address: Arsenalsgatan 8c, S-10 |
